2 recruiting, 1 active not recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 2 |
| Phase 2 | 2 | Recruiting 2 |
Follow AAVantgarde Bio Srl: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of AAVB-039 in Participants With Stargardt Disease (STGD1) AAVB-039 - Stargardt Disease | Phase 1 / Phase 2 | Recruiting | AAVantgarde Bio Srl | 75 | 2025-09-29 | 2026-09-30 |
| Study of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa AAVB-081 - Usher Syndrome, Type 1B | Phase 1 / Phase 2 | Recruiting | AAVantgarde Bio Srl | 15 | 2024-07-02 | 2025-05-02 |
| An Observational Study in Children and Adults With Stargardt Disease Stargardt Disease | Active not recruiting | AAVantgarde Bio Srl | 80 | 2024-05-01 | 2026-06-16 |
Stargardt Disease (2) · Retinitis Pigmentosa (1) · Usher Syndromes (1) · Usher syndrome, type 1B (1)
Norway (2) · United Kingdom (2) · United States (2) · Italy (1)